Literature DB >> 21395496

Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions.

Dmitri R Davydov1.   

Abstract

INTRODUCTION: There is increasing evidence of physical interactions (association) among cytochromes P450 in the membranes of the endoplasmic reticulum. Functional consequences of these interactions are often underestimated. AREAS COVERED: This article provides a comprehensive overview of available experimental material regarding P450-P450 interactions. Special emphasis is given to the interactions between different P450 species and to the functional consequences of homo- and heterooligomerization. EXPERT OPINION: Recent advances provide conclusive evidence for a substantial degree of P450 oligomerization in membranes. Interactions between different P450 species resulting in the formation of mixed oligomers with altered activity and substrate specificity have been demonstrated clearly. There are important indications that oligomerization impedes electron flow to a fraction of the P450 population, which renders some P450 species nonfunctional. Functional consequences of P450-P450 interactions make the integrated properties of the microsomal monooxygenase remarkably different from a simple summation of the properties of the individual P450 species. This complexity compromises the predictive power of the current in vitro models of drug metabolism and warrants an urgent need for development of new model systems that consider the interactions of multiple P450 species.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395496      PMCID: PMC3079778          DOI: 10.1517/17425255.2011.562194

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  134 in total

1.  Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications.

Authors:  Natalia Mast; Ulla Andersson; Kazuo Nakayama; Ingemar Bjorkhem; Irina A Pikuleva
Journal:  Arch Biochem Biophys       Date:  2004-08-01       Impact factor: 4.013

2.  Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.

Authors:  H Yamazaki; E M Gillam; M S Dong; W W Johnson; F P Guengerich; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

3.  Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.

Authors:  Y Tan; C J Patten; T Smith; C S Yang
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

4.  Conformation and rotational diffusion of cytochrome P-450 changed by substrate binding.

Authors:  R Greinert; S A Finch; A Stier
Journal:  Biosci Rep       Date:  1982-12       Impact factor: 3.840

5.  Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.

Authors:  A C Kempf; U M Zanger; U A Meyer
Journal:  Arch Biochem Biophys       Date:  1995-08-20       Impact factor: 4.013

6.  Effect of glutathione on homo- and heterotropic cooperativity in cytochrome P450 3A4.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Tamara N Tsalkova; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2008-01-11       Impact factor: 4.013

7.  Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.

Authors:  Ana M Gomes; Stefan Winter; Kathrin Klein; Miia Turpeinen; Elke Schaeffeler; Matthias Schwab; Ulrich M Zanger
Journal:  Pharmacogenomics       Date:  2009-04       Impact factor: 2.533

8.  Expression of microsomal lanosterol 14alpha-demethylase (CYP51) in an engineered soluble monomeric form.

Authors:  Matej Seliskar; Rok Kosir; Damjana Rozman
Journal:  Biochem Biophys Res Commun       Date:  2008-05-06       Impact factor: 3.575

9.  Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.

Authors:  S J Pernecky; N M Olken; L L Bestervelt; M J Coon
Journal:  Arch Biochem Biophys       Date:  1995-04-20       Impact factor: 4.013

10.  Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.

Authors:  I P Kanaeva; O V Nikityuk; D R Davydov; I R Dedinskii; Y M Koen; G P Kuznetsova; E D Skotselyas; G I Bachmanova; A I Archakov
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

View more
  33 in total

1.  Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; James R Halpert
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

Review 2.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

3.  Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of α-naphthoflavone.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Elena V Sineva; Irina Kufareva; James R Halpert
Journal:  Biochem J       Date:  2013-07-15       Impact factor: 3.857

4.  Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Xenobiotica       Date:  2020-07-26       Impact factor: 1.908

Review 5.  Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomography.

Authors:  Peter Brust; Jörg van den Hoff; Jörg Steinbach
Journal:  Neurosci Bull       Date:  2014-08-29       Impact factor: 5.203

6.  Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.

Authors:  Ilia G Denisov; Javier L Baylon; Yelena V Grinkova; Emad Tajkhorshid; Stephen G Sligar
Journal:  Biochemistry       Date:  2017-12-14       Impact factor: 3.162

Review 7.  A novel type of allosteric regulation: functional cooperativity in monomeric proteins.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2012-01-08       Impact factor: 4.013

Review 8.  BAX inhibitor-1: between stress and survival.

Authors:  Cynthia Lebeaupin; Marina Blanc; Déborah Vallée; Harald Keller; Béatrice Bailly-Maitre
Journal:  FEBS J       Date:  2020-01-08       Impact factor: 5.542

9.  Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; John T Rodgers; Thomas H Rushmore; Jeffrey P Jones
Journal:  Biochem J       Date:  2017-10-10       Impact factor: 3.857

10.  Interactions between cytochromes P450 2B4 (CYP2B4) and 1A2 (CYP1A2) lead to alterations in toluene disposition and P450 uncoupling.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Biochemistry       Date:  2013-05-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.